EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk factors for distant recurrence in patients with rectal cancer supporting selection for total neoadjuvant therapy

Anna Baech Slipsager iD, Rana Bahij iD, Heidi Søgaard Christensen iD, Laura Vittrup Diness iD, Birgitte Mayland Havelund iD, Anne Ramlov iD, Signe Korsgaard Skriver iD, Joanna Eliza Szpejewska, Olga Tcacenco iD, Christian Thomsen iD, Laurids Østergaard Poulsen iD

Acta Oncologica · 17.04.2026 · 65 · 289-296

DOI: 10.2340/ao.v65.45169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Oncologica, online erschienen am 17.04.2026. Verfasst von Anna Baech Slipsager und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Aalborg University Hospital, Aalborg, Denmark; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark…. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoadjuvant Therapy, Neoplasm Recurrence, Local. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose: In locally advanced rectal cancer, distant recurrence remains a major challenge. Total neoadjuvant therapy (TNT) has been implemented to reduce this risk. Identification of risk factors for distant recurrence to support selection of TNT is crucial to avoid excessive treatment. This study aimed to identify magnetic resonance imaging (MRI) features predictive of distant recurrence in patients with rectal cancer.Material and methods: In this national retrospective cohort study, all patients were diagnosed with non-metastatic rectal cancer between 2016 and 2020 and received neoadjuvant radiotherapy followed by surgery. MRI features from the diagnostic report, including cT-stage, cN-stage, clinical extramural vascular invasion (cEMVI), distance to the mesorectal fascia (MRF), and tumor deposit, were registered. The primary endpoint was distant recurrence.

Results

A total of 648 patients were included in the study. In multivariate analysis using multiple imputation, risk factors significantly associated with distant recurrence were cT3c/cT3d/cT4-stage (hazard ratio [HR]: 1.8), cEMVI positive tumors (HR: 2.05), and cT3-stage tumors with a distance to MRF of ≤ 2 mm (HR: 1.51) compared with patients with cT1/cT2/cT3/cT3a/cT3b-stage, cEMVI negative tumors, and cT3-stage tumors with a distance to MRF > 2 mm, respectively. The cN-stage was not significantly associated with distant recurrence. Due to 67% missing data on tumor deposit status, the results regarding this feature cannot be considered conclusive.

Interpretation

In this study, cT-stage, cEMVI status, and distance to MRF are prognostic features for risk stratification for patients receiving neoadjuvant radiotherapy. These results may be used for selecting patients for future treatment strategies such as TNT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsNeoadjuvant TherapyNeoplasm Recurrence, LocalHumansFemaleRetrospective StudiesRisk FactorsMaleMagnetic Resonance ImagingMiddle AgedAgedNeoplasm StagingAdult

Autor:innen und Institutionen

  • Department of Oncology, Aalborg University Hospital, Aalborg, Denmark; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmar…
  • Department of Oncology, Odense University Hospital, Odense, Denmark.
  • Center for Clinical Data Science, Aalborg University, Aalborg, Denmark.
  • Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.
  • Department of Oncology, University Hospital of Southern Denmark, Lillebaelt Hospital, Vejle, Denmark.
  • Department of Oncology, Aarhus University Hospital, Skejby, Denmark.

ORCID-Profile: Anna Baech Slipsager, Rana Bahij, Heidi Søgaard Christensen, Laura Vittrup Diness, Birgitte Mayland Havelund, Anne Ramlov, Signe Korsgaard Skriver, Olga Tcacenco, Christian Thomsen, Laurids Østergaard Poulsen

Zitieren

APA

Slipsager, A. B., Bahij, R., Christensen, H. S., Diness, L. V., Havelund, B. M., Ramlov, A., Skriver, S. K., Szpejewska, J. E., Tcacenco, O., Thomsen, C., & Poulsen, L. Ø. (2026). Risk factors for distant recurrence in patients with rectal cancer supporting selection for total neoadjuvant therapy. Acta Oncologica, 65, 289-296. https://doi.org/10.2340/ao.v65.45169

Vancouver

Slipsager AB, Bahij R, Christensen HS, Diness LV, Havelund BM, Ramlov A, et al. Risk factors for distant recurrence in patients with rectal cancer supporting selection for total neoadjuvant therapy. Acta Oncologica. 2026;65:289-296. doi:10.2340/ao.v65.45169

BibTeX
@article{Slipsager2026,
  author = {Slipsager, Anna Baech and Bahij, Rana and Christensen, Heidi Søgaard and Diness, Laura Vittrup and Havelund, Birgitte Mayland and Ramlov, Anne and Skriver, Signe Korsgaard and Szpejewska, Joanna Eliza and Tcacenco, Olga and Thomsen, Christian and Poulsen, Laurids Østergaard},
  title = {Risk factors for distant recurrence in patients with rectal cancer supporting selection for total neoadjuvant therapy},
  journal = {Acta Oncologica},
  year = {2026},
  volume = {65},
  pages = {289--296},
  doi = {10.2340/ao.v65.45169}
}
Kostenlos starten →